Table 5.
Ratings of app quality based on the engagement, functionality, aesthetics, and information quality subscales of the MARS.21
| App name | Version | Developer | Cost (Canadian $) | Engagement | Functionality | Aesthetics | Information quality | Mean MARS quality score |
|---|---|---|---|---|---|---|---|---|
| LyfeMD | 1.2 | LyfeMD Inc. | No charge | 3.2 | 3.0 | 3.7 | 3.9 | 3.4 |
| My IBD care: Crohn’s and Colitis | 4.1.1 | Ampersand Health Limited | No charge | 3.9 | 3.9 | 4.3 | 4.8 | 4.2 |
| MyGut | 1.1.2 | Crohn’s and Colitis Canada | No charge | 2.6 | 3.6 | 4.5 | 3.8 | 3.6 |
| Colitis Diarya | 1.7.98 | cellHigh | 6.99 | 2.7 | 3.4 | 2.7 | 3.0 | 2.9 |
| Crohn’s Diarya | 1.7.98 | cellHigh | 6.99 | 2.7 | 3.4 | 2.7 | 3.0 | 2.9 |
| IBD fighter | 1.2.3 | WoMoApp., s.r.o. | No charge | 1.8 | 4.1 | 3.3 | 2.6 | 3.0 |
Abbreviations: MARS, mobile application rating scale.
aUsed the same platform by the same developer, but with different titles.